Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies

Learn about risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccine strategies for older adults.
Spencer Durham Headshot
Spencer H. Durham, PharmD, BCPS, BCIDP
person default
Stefan Gravenstein, MD, MPH
Barbara Resnick, PhD, CRNP
Format: Microsoft PowerPoint (.ppt)
File Size: 507 KB
Released: June 25, 2021


This activity is provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Janssen Therapeutics, Division of Janssen Products, LP

Related Content

Expert insights on special considerations for individuals with HCV in ethnically diverse populations, from Ahmed M. Elsharkawy PhD, FRCP(UK), and Clinical Care Options (CCO)

person default Ahmed M. Elsharkawy, PhD, FRCP(UK) Released: December 1, 2021

Complimentary slides from CCO featuring an in-depth analysis of HCV burden and care disparities in specific populations and strategies to reduce disparities.

Released: December 1, 2021

CCO slides on the impact of racial disparities in HCV care; key strategies on recognizing and reducing inadequate HCV care in the US and globally

Prof Ashley Brown, BSc, MD, FRCP person default Ahmed M. Elsharkawy, PhD, FRCP(UK) Oluwaseun Falade-Nwulia, MBBS, MPH Joseph K. Lim, MD Released: October 11, 2021

Expert CCO commentary on racial disparities in HCV care among the Pakistani immigrant community in London, UK

Shabana Begum Graham R. Foster, FRCP, PhD Released: June 14, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings